Jun 08, 2022 / 03:30PM GMT
Operator
Welcome to the 2022 Annual Stockholders' Meeting of Beam Therapeutics. I will now turn the call over to John Evans, Chief Executive Officer of Beam.
John Evans - Beam Therapeutics Inc. - CEO & Director
Thank you, and thanks for joining us today. My name is John Evans, and I'm the Chief Executive Officer and a Director of Beam Therapeutics. Beam Therapeutics is a biotechnology company developing precision genetic medicines through a new form of gene editing called base editing. I'm pleased to welcome you to our 2022 Annual Meeting of Stockholders.
We are excited to be hosting our virtual meeting live via webcast, which allows us to be more inclusive and reach a greater number of our stockholders. As a company focused on the development and commercialization of innovative therapies, we view this meeting format as a way to be more efficient in our meeting process, which ultimately benefits all of our shareholders.
Hosting a virtual annual meeting also safely and efficiently facilitates shareholder attendance and participation fully and
Beam Therapeutics Inc Annual Shareholders Meeting Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot